2010 Cannabinoids Epilepsy Oil 
Cannabis Law Report
SEPTEMBER 3, 2021
Cannabis oil is also known as honey oil or hush oil. This oil is obtained from the extraction of hashish or Cannabis. It includes tetrahydrocannabinol, cannabis oil, and other cannabinoids. An oleoresin carries essential oil, fatty oils of nature, and an artificial mixture.
Cannabis Law Report
JANUARY 15, 2019
British firm GW Pharmaceuticals is licking its wounds after US judges tossed out its attempt to patent multiple cannabinoids for epilepsy treatment following an eight-year battle. The patent, which has been embroiled in dispute since 2010, is for “the use of one or more cannabinoids in the treatment of epilepsy”.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Puff Puff Post
DECEMBER 28, 2018
One recent observational study has shown an astonishing success rate of 80% in reducing negative behavioral patterns in test subjects by using CBD oil. We go deep into what this might mean for the future of therapy for Autism Spectrum Disorders (ASD), and how we might see the use of CBD oil for autism. CBD Oil For Autism: Highlights.
CannaMD
AUGUST 8, 2020
In honor of National CBD Day, CannaMD wants to clear up some cannabinoid confusion once and for all. When people say they’re buying or using “CBD,” they’re referring to products (most often oils) that are rich in this compound. However, many of these products contain a number of other cannabinoids as well.
Miss Marijuana
MAY 9, 2021
Today we will take an in-depth look at the effects, benefits, and uses of three cannabinoids: CBD, CBN, and CBG. Cannabidiol, also known as CBD, is one of the two most essential cannabinoid components of the cannabis plant, found in varying proportions depending on the strain. CBG is one of the many cannabinoids in cannabis and hemp.
Alchimia
JUNE 20, 2016
CBD is a cannabinoid present in cannabis plants with a very similar molecular structure to THC but without any kind of psychoactive effect. It has been demonstrated that CBD has low affinity with the CB1 and CB2 cannabinoid receptors , but it does act on other receptors of the human body like GPR55 or 5-HT1A. What is CBD?
Cannabis Law Report
SEPTEMBER 23, 2019
Marijuana and Cannabinoids: Health, Research and Regulatory Considerations (Position Paper). 1 Simultaneously, the AAFP acknowledges preliminary evidence indicates marijuana and cannabinoids may have potential therapeutic benefits, while also recognizing subsequent negative public health and health outcomes associated with cannabis use.
Expert insights. Personalized for you.
Let's personalize your content